Diabetes Insipidus - 29 Studies Found

Completed : Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
:
  • Inappropriate ADH Syndrome
  • Hyponatremia

: 2005-12-12
: Drug: SR121463B
Completed : Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
:
  • Syndrome of Inappropriate ADH (SIADH) Secretion
  • Hyponatremia

: 2002-03-29
: Drug: satavaptan (SR121463B)
Completed : V2 Receptor Effects on Fluid Regulation and Performance
:
  • Electrolyte Imbalance
  • Hyponatremia
  • Hypernatremia
    • : 2014-03-10
    : Drug: V2R (Vasopressin 2 receptor) All ten subjects were used as their own controls in this double-blind
Completed : Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin
:
  • Chronic Hepatitis C
  • Chronic Hepatitis B
  • Biopsy
  • : 2008-03-05
    : Procedure: Percutaneous liver biopsy Two passes of PLB from the right hepatic lobe by US guidance (Toshi
Recruiting : Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)
: Primary Polydipsia
: 2016-03-30
:
  • Drug: Dulaglutide Treatment wi
Completed : Copeptin in Differentiation of Polyuria and Polydipsia
:
  • Polyuria
  • Polydipsia

: 2010-01-25
Completed : Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).
: Chronic Heart Failure
: 2002-03-29
: Drug: Vasopressin V2 Receptor Antagonist
Completed : DILIPO (DILutIonal HyPOnatremia)
: Congestive Heart Failure
: 2006-01-09
: Drug: SR121463B
NOT_YET_RECRUITING : Effects of Intranasal Oxytocin in Patients With Central Diabetes Insipidus
: Central Diabetes Insipidus
: 2024-11-21
: 4 IU intranasal oxytocin, 24 IU intranasal oxytocin or placebo
<<< Previous